what is in compound tirzepatide Compounded Explained: Key Facts to Know FDA Allows Compounded Tirzepatide During

It is a once-weekly subcutaneous injection indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or who are overweight

Robert Popovian 01:07 Today well be talking about biosimilars

Antioxid Redox Signal 23(14):11441170

This condition is called atherosclerosis

Hormonal changes can make weight gain harder to control even when diet and exercise habits haven't changed

We are entering a new era of obesity care where patients want individualized treatment plans that address their needs and provide choices, including oral formulations, said Anna Windle, PhD, Senior Vice President, Clinical Development, Medical & Regulatory Affairs at Novo Nordisk Inc, in a May 2, 2025, statement